Throughout 2024, Antitrust Byte covered a variety of antitrust issues that should be top of mind for stakeholders in the health care industry.
In case you missed any, below are links to Antitrust Bytes covering the top 10 issues from last year:
- FTC Receives Grades for Its FY 2024 Performance
- FTC Requests Substantial Increase to FY 2025 Budget
- Agencies Seek Information on Serial Acquisitions
- FTC Releases Controversial Interim Staff Report on PBMs' Purported Impact on Drug Prices
- FTC Disputes Whether States Can Effectively Displace Hospital Competition with COPA Regulation
- FTC and DOJ Signal Continued Interest in Labor Markets with New MOU
- Updated Merger Guidelines Finalized
- Close of Comment Period for RFI on Consolidation in Health Care Markets
- Newly Appointed Commissioner Holyoak Criticizes FTC's Direction and Policy
- FTC Debuts New Comment Portal
* * *
For additional information about the issues discussed in this Antitrust Byte, or if you have any other antitrust concerns, please contact the attorneys listed on this page or the Epstein Becker Green attorney who regularly handles your legal matters.
People
- Member of the Firm
- General Counsel / Chief Privacy Officer
- Member of the Firm